셀리드

299660KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

2,340KRWMarket close of 10/21 (Wed)

Up +0.43%+10KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)2,175KRWDown -7.05%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,390
High
2,390
Low
2,305
Day range
Day range low 2,305 high 2,390, open 2,390, close 2,340, previous close 2,330
Volume
15×10K shares
363.90 million KRW 0.12× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 1,025 to 4,110 won, 43% up from the low

43% of the way up from the lowest close in 1 year (252 sessions) · -43.1% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move+0.43%usual range
  • Trading value0.1×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Filings in the last 2 years · 0

Annual reportHalf-year reportQuarterly reportMaterial eventAmended

Material events are checked for the top 400 stocks only — this stock shows periodic reports only.

  1. 2024-05-16Quarterly report (2024.03)

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.